Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

AIM movers: High grades for Rockfire Resources and Pan African Resources reduces gold production guidance

Fevertree sales build momentum

AIM movers: Mercantile Ports contract and ex-dividends

New standard listing: Admiral Acquisition

AIM movers: Enwell Energy dividend boost

AIM movers: Southern Energy buys acreage in Mississippi and Eneraqua Technologies downgrade

Marks & Spencer upgraded ahead of results

Chill Brands UK distribution deal

AIM movers: Norman Broadbent grows revenues and Barryroe project rejected by Irish government

Aquis weekly movers: Asimilar to concentrate on Aquis quotation

AIM weekly movers: Egdon Resources agrees bid

AIM movers: IQE share price recovers and Fusion Antibodies heavily discounted fundraising

AIM movers: SRT Marine contract gain and ex-dividends

IQE seeks investment for growth sectors

Hardide progresses towards breakeven

Antenna profit boost for MTI Wireless

Frasers increases stake in ASOS

AIM movers: Egdon Resources recommends bid and Purplebricks sells business

Angling Direct builds European sales

AIM movers: Rurelec sells interests in Argentina and Tower Resources discounted placing

Why companies left AIM in April 2023

Instem gains rights to data sharing platform

Cerillion goes from strength to strength

AIM movers: Celsius Resources bid and Orcadian Energy loses licence

New AIM admission: Golden Metal Resources

Aquis weekly movers: TruSpine Technologies recovers despite failing to disclose information

AIM weekly movers: Capital Metals joint venture agreement

AIM movers: Cancellation hits Blackbird and Itsarm meeting adjourned

Tough times for CMO Group

AIM movers: Block Energy production increases and ex-dividends

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020